Manufacture of pharmaceutical preparations
PROPHYLIX AS
Operating profit
NOK −311,000
Equity
NOK −13.2m
Incorporated
2017
Share capital
NOK 200,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating costs | 311k | |
| Operating profit (EBIT) | −311k | |
| Net financial items | −958k | |
| Profit for the year | −1.1m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 900k | |
| of which current assets | 900k | |
| Equity | −13.2m | |
| Total liabilities | 14.1m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.